Cision PR Newswire APAC#press
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Updatetranslating…
4h agoFactuality: 84/100UnknownCision Communications
Completed underwritten public offering with gross proceeds of $66.0 million and uplisting to the Nasdaq Capital Market, significantly strengthening the Company's balance sheet Phase 2b clinical trial of exaluren in nonsense mutation Alport syndrome expected to initiate in the…